Literature DB >> 14767292

Urodynamic study of women in urinary retention treated with sacral neuromodulation.

Ranan DasGupta1, Clare J Fowler.   

Abstract

PURPOSE: We investigated the action of sacral neuromodulation in restoring voiding function in women with urinary retention attributable to sphincter overactivity (Fowler's syndrome).
MATERIALS AND METHODS: We recruited women within retention who were able to void following neuromodulation by temporary test stimulation or a permanent implant. Urethral pressure profiles, cystometry and sphincter electromyography were performed before and after neuromodulation.
RESULTS: A total of 30 women 19 to 52 years old were recruited, including 21 with a permanent implant and 9 undergoing temporary stimulation. Mean maximum urethral closure pressure was elevated compared to expected pressure and it did not change significantly after neuromodulation. The electromyographic abnormality persisted during neuromodulation and voiding was often done with an interrupted flow. There was a slight increase in detrusor contractility.
CONCLUSIONS: This evidence suggests that neuromodulation does not restore voiding in these patients by a direct relaxant effect on the sphincter. The modest increase in detrusor pressure appears to be sufficient to overcome the resistance of the overactive sphincter.

Entities:  

Mesh:

Year:  2004        PMID: 14767292     DOI: 10.1097/01.ju.0000113201.26176.8f

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

Review 1.  Sacral neuromodulation for lower urinary tract dysfunction.

Authors:  Philip E V Van Kerrebroeck; Tom A T Marcelissen
Journal:  World J Urol       Date:  2011-10-12       Impact factor: 4.226

Review 2.  Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.

Authors:  Robert D Mayer; Fred M Howard
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 3.  Sacral neuromodulation and lower urinary tract dysfunction in cerebral palsy.

Authors:  Ted M Roth
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-28

4.  Sacral neuromodulation blocks pudendal inhibition of reflex bladder activity in cats: insight into the efficacy of sacral neuromodulation in Fowler's syndrome.

Authors:  Xing Li; Jamie Uy; Michelle Yu; Shun Li; Katherine Theisen; Jeffery Browning; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-20       Impact factor: 3.619

5.  Superficial peroneal neuromodulation of nonobstructive urinary retention induced by prolonged pudendal afferent activity in cats.

Authors:  Jialiang Chen; Yihua Zhong; Bing Shen; Jicheng Wang; Zhijun Shen; Jonathan Beckel; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-01-05       Impact factor: 3.619

Review 6.  Fowler's syndrome--a cause of unexplained urinary retention in young women?

Authors:  Nadir I Osman; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2013-12-10       Impact factor: 14.432

Review 7.  Bladder outlet obstruction in women: functional causes.

Authors:  Ashley B King; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

8.  Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization.

Authors:  Serge P Marinkovic; Lisa M Gillen
Journal:  Int Urogynecol J       Date:  2009-10-30       Impact factor: 2.894

Review 9.  Fowler's Syndrome-The Cause of Urinary Retention in Young Women, Often Forgotten, but Significant and Challenging to Treat.

Authors:  Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Grzegorz Jakiel
Journal:  Int J Environ Res Public Health       Date:  2021-03-23       Impact factor: 3.390

10.  Sacral neuromodulation to treat voiding dysfunction in patients with previous pelvic surgery for deep infiltrating endometriosis: our centre's experience.

Authors:  Marco Agnello; Mario Vottero; Paola Bertapelle
Journal:  Int Urogynecol J       Date:  2020-08-15       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.